PROTHENA CORP PUBLIC LTD CO — Director's Dealing 2021

Jun 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTHENA CORP PUBLIC LTD CO (PRTA)
CIK: 0001559053
Period of Report: 2021-06-25

Reporting Person: HENNEY CHRISTOPHER S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-25	Ordinary Shares, par value $0.01 per share	M	12000	$16.43	Acquired	12000	Direct
2021-06-25	Ordinary Shares, par value $0.01 per share	S	10264	$47.5665	Disposed	1736	Direct
2021-06-25	Ordinary Shares, par value $0.01 per share	S	1736	$48.7308	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-25	Stock Option (Right to Buy)	$16.43	M	12000	Acquired	2028-05-16	Ordinary Shares (12000)	Direct

Footnotes

F1: The transaction was executed in multiple trades in prices ranging from $47.18 to $48.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2: The transaction was executed in multiple trades in prices ranging from $48.23 to $49.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: The shares subject to the option were fully vested as of the date of the exercise.